{
    "clinical_study": {
        "@rank": "13410", 
        "arm_group": [
            {
                "arm_group_label": "sublingual misoprostol & rectal placebo", 
                "arm_group_type": "Experimental", 
                "description": "will receive 400 microgram of misoprostol (Sigma) sublingual \"2 tablets\" and rectal placebo\"2 tablets\"."
            }, 
            {
                "arm_group_label": "rectal & sublingual placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "will receive rectal placebo\"2 tablets\" and sublingual placebo\"2 tablets\"."
            }, 
            {
                "arm_group_label": "rectal misoprostol & sublingual placebo", 
                "arm_group_type": "Experimental", 
                "description": "will receive 400 microgram of misoprostol (Sigma) rectal \"2 tablets\" and sublingual placebo\"2 tablets\"."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the work is to evaluate & compare the effectiveness of rectally administered PGE1\n      synthetic analogue (misoprostol) 400 microgram versus sublingually administered misoprostol\n      before caesarean section to decrease blood loss during and after the operation."
        }, 
        "brief_title": "Comparison Between Rectal & Sublingual Misoprostol Before Caesarian Section To Reduce Intra & Post-Operative Blood Loss", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "condition": "Postpartum Hemorrhage", 
        "condition_browse": {
            "mesh_term": [
                "Hemorrhage", 
                "Postoperative Hemorrhage", 
                "Postpartum Hemorrhage"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patients booked for elective cesarean section.\n\n          2. Singleton pregnancies. 3- Full term pregnancies (GA 37-42 weeks). 4- Patients with\n             only previous one cesarian section\n\n        Exclusion Criteria:\n\n          1. Primigravida.\n\n          2. Blood dyscrasias.\n\n          3. Large fibroids.\n\n          4. Multiple pregnancies.\n\n          5. Overdistended uterus eg. Hydramnios.\n\n          6. Pre-eclampsia.\n\n          7. Marked maternal anemia (Preoperative hemoglobin < 9 gm/dl).\n\n          8. Previous history of PPH.\n\n          9. Contraindications to prostaglandin therapy (e.g. history of severe bronchial asthma\n             or allergy to misoprostol.\n\n         10. Placenta previa.\n\n         11. Contraindication to spinal anesthesia.\n\n         12. Previous myomectomy.\n\n         13. Previous two or more C.S."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "38 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "635", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02083107", 
            "org_study_id": "9021344"
        }, 
        "intervention": {
            "arm_group_label": [
                "sublingual misoprostol & rectal placebo", 
                "rectal misoprostol & sublingual placebo"
            ], 
            "description": "Comparison of different routes of administration of 400 micro gram misoprostol", 
            "intervention_name": "Misoprostol", 
            "intervention_type": "Drug", 
            "other_name": [
                "Misotac", 
                "Cytotec"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": "Misoprostol"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Postpartum hemorrhage", 
            "Intrapartum blood loss", 
            "Misoprostol"
        ], 
        "lastchanged_date": "March 10, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Cairo", 
                    "country": "Egypt"
                }, 
                "name": "Ain Shams University Maternity Hospital"
            }
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "3", 
        "official_title": "COMPARISON BETWEEN RECTAL & SUBLINGUAL MISOPROSTOL BEFORE CAESARIAN SECTION TO REDUCE INTRA & POST-OPERATIVE BLOOD LOSS", 
        "other_outcome": {
            "measure": "Changes in hemoglobin concentration and hematocrite value", 
            "safety_issue": "No", 
            "time_frame": "24 hours postoperative"
        }, 
        "overall_official": [
            {
                "affiliation": "Ain Shams University", 
                "last_name": "Mohamed S. Sweed, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "AinShams University", 
                "last_name": "Mourad M. El-Said, Professor", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "AinShams university", 
                "last_name": "Amgad E. Abou-Gamrah, Ass.Prof.", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "AinShams University", 
                "last_name": "Haitham El-Sabe, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "AinShams University", 
                "last_name": "Mohamed M. AbdEl-Hamid, Registrar", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Egypt: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "intraoperative blood loss", 
            "safety_issue": "Yes", 
            "time_frame": "at time of surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02083107"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ain Shams University", 
            "investigator_full_name": "Mohamed S Sweed, MD", 
            "investigator_title": "Mohamed S. Sweed, Lecturer of Obstetrics &Gynecology, Ain Shams University", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "The incidence of side effects of the drug will be noted for all cases. Postoperative bowel habits. Postoperative pain. APGAR score. The need for extra ecbolics. The need for extra analgesics.", 
            "safety_issue": "Yes", 
            "time_frame": "first day postoperative"
        }, 
        "source": "Ain Shams University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ain Shams University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}